Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 18(5): 1668-73, 2008 Mar 01.
Article in English | MEDLINE | ID: mdl-18243701

ABSTRACT

A series of tri- and tetra-substituted naphthalene diimides have been designed and synthesized. Several compounds show exceptional affinity for telomeric G-quadruplex DNA in classical and competition FRET assays and SPR studies. They inhibit telomerase in the TRAP assay, and show potent senescence-based short-term anti-proliferative effects on MCF7 and A549 cancer cell lines, and localize in the nucleus and particularly the nucleolus of MCF7 cells.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , G-Quadruplexes , Phenanthrolines/chemistry , Phenanthrolines/metabolism , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Fluorescence Resonance Energy Transfer , Humans , Imides , Ligands , Models, Molecular , Molecular Structure , Naphthalenes , Phenanthrolines/pharmacology , Telomerase/antagonists & inhibitors
2.
Biochem Pharmacol ; 74(5): 679-89, 2007 Sep 01.
Article in English | MEDLINE | ID: mdl-17631279

ABSTRACT

The trisubstituted acridine compound BRACO-19 has been developed as a ligand for stabilising G-quadruplex structures. It is shown here that BRACO-19 produces short- and long-term growth arrest in cancer cell lines, and is significantly less potent in a normal cell line. BRACO-19 reduces telomerase activity and long-term telomere length attrition is observed. It is also shown that BRACO-19 binds to telomeric single-stranded overhang DNA, consistent with quadruplex formation, and the single-stranded protein hPOT1 has been shown to be displaced from the overhang in vitro and in cellular experiments. It is concluded that the cellular activity of BRACO-19 can be ascribed both to the uncapping of 3' telomere ends and to telomere shortening that may preferentially affect cells with short telomeres.


Subject(s)
Acridines/pharmacology , Antineoplastic Agents/pharmacology , Telomerase/antagonists & inhibitors , Telomere/metabolism , Acridines/chemistry , Antineoplastic Agents/chemistry , Cell Line , Dose-Response Relationship, Drug , Humans , Molecular Structure
3.
Bioorg Med Chem Lett ; 17(8): 2293-8, 2007 Apr 15.
Article in English | MEDLINE | ID: mdl-17276687

ABSTRACT

The design, synthesis, biophysical and biochemical evaluation is presented of a new series of benzylamino-substituted acridines as G-quadruplex binding telomerase inhibitors. Replacement of the previously reported anilino substituents by benzylamino groups results in enhanced quadruplex interaction, and for one compound, superior telomerase inhibitory activity.


Subject(s)
Acridines/chemical synthesis , Benzylamines/chemical synthesis , DNA/drug effects , Telomerase/antagonists & inhibitors , Telomere/drug effects , Acridines/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Benzylamines/pharmacology , Drug Delivery Systems , Drug Design , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , G-Quadruplexes , Guanosine , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...